PRIMA will develop the next generation of precision immunotherapy

Mission Statement

PRIMA is dedicated to transform cancer treatment through cutting-edge research and innovation in precision immunotherapy. Our mission is to identify novel immune targets and effector molecules, overcome immune suppression and exclusion, develop advanced engineering technologies and designer biologics, and seamlessly integrate and translate these discoveries into effective immunotherapies for cancer patients worldwide.